Corrigendum to "First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer IMpassion130 final overall survival analysis": Annals of Oncology 2021; 32: 983-993

Saved in:
Bibliographic Details
Main Authors: Emens, Leisha Ann (Author) , Adams, S. (Author) , Barrios, C. H. (Author) , Diéras, V. (Author) , Iwata, H. (Author) , Loi, S. (Author) , Rugo, H. S. (Author) , Schneeweiss, Andreas (Author) , Winer, E. P. (Author) , Patel, S. (Author) , Henschel, V. (Author) , Swat, A. (Author) , Kaul, M. (Author) , Molinero, L. (Author) , Chui, S. Y. (Author) , Schmid, P. (Author)
Format: Article (Journal)
Language:English
Published: 2 November 2021
In: Annals of oncology
Year: 2021, Volume: 32, Issue: 12, Pages: 1650
ISSN:1569-8041
DOI:10.1016/j.annonc.2021.10.002
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2021.10.002
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753421045208
Get full text
Author Notes:L.A. Emens, S. Adams, C.H. Barrios, V. Diéras, H. Iwata, S. Loi, H.S. Rugo, A. Schneeweiss, E.P. Winer, S. Patel, V. Henschel, A. Swat, M. Kaul, L. Molinero, S. Patel, S.Y. Chui & P. Schmid
Description
Item Description:Gesehen am 03.02.2022
Physical Description:Online Resource
ISSN:1569-8041
DOI:10.1016/j.annonc.2021.10.002